|
|
|
|
In this multicenter,randomized,blinded study there were no differences in outcome between vidarabine and acyclovir in the treatment of neonatal HSV infection.The study lacked statistical power to determine whether there were sizable differences within the subgroups of those with localized HSV, encephalitis,or disseminated disease. |
|